Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
44 Cards in this Set
- Front
- Back
What are the normal processes of blood clot formation and breakdown referred to as?
|
Hemostasis
Fibrinolysis |
|
What is Thrombosis?
|
Inappropriate activation of the normal hemostatic process within the normal non-interrupted vascular system.
|
|
What are the 4 main steps in the normal sequence of hemostasis?
|
Arteriolar vasoconstriction
Exposure of sub-endothelial ECM Tissue Factor released at injury site Formation of Permanent Plug |
|
What occurs during the first step of hemostasis (vasoconstriction)?
|
Vasoconstriction (transient)
|
|
What occurs during the second step of hemostasis (platelet adhesion)?
|
Sub-endothelial ECM is exposed (has collagen which is highly thrombogenic)
Platelets adhere and become activated (they change shape and release secretory products Thromboxane, ADP, Serotonin) |
|
What does this second step lead to?
What is this called? |
Hemostatic plug
Primary Hemostasis |
|
What occurs in the third step (TF release)?
|
It works with secreted platelet factors
Activates coagulation cascade Thrombin is activated Fibrin is formed |
|
What is this third step referred to as?
|
Secondary Hemostasis
|
|
What occurs in the fourth step (permanent plug)?
|
Fibrin polymerizes and further platelet aggregation occurs
Counter regulatory mechanisms (t-PA) limit the plug to the site of injury. |
|
Describe the basics of the Intrinsic Cascade.
|
It is activated by surface contact with a foreign body
Factor 9a converts 10 to 10a 10a converts prothombin to thrombin and thrombin converts fibrinogen to fibrin |
|
Describe the main points of the extrinsic pathway.
|
Activated by Tissue Injury
Factor 7a/Tissue Factor convert 10 to 10a 10a (activated) converts prothrombin to thrombin Thrombin converts fibrinogen to fibrin |
|
What are antithrombins?
What is the effect of Heparin on these molecules? |
They are molecules that inhibit clotting by inactivating various clotting factors, factor 10a, and thrombin.
Heparin greatly increases thrombin inactivation |
|
What are proteins C and S?
|
Vitamin K dependent factors that inactivate cofactors 5a and 8a.
|
|
What is the role of the plasminogen-plasmin system?
|
It breaks down fibrin and inhibits its polymerization
Split fibrin products are anticoagulants |
|
What is vWF?
|
vonWillebrand factor - produced by normal endothelium, found in plasma, essential for platelet binding to collagen and other surfaces
|
|
What other factor is secreted by the endothelial cells?
What induces this factor? |
Tissue Factor
Cytokines TNF and IL-1 |
|
Endothelial cells have pro-thrombotic (vWF, TF) and anti-thrombotic effects.
Describe the anti-thrombotic effects. |
Anti-platelet - Intact cells are a barrier to sub-endothelial ECM, PGI-2 and NO prevent platelet adhesion
Fibrinolytic - t-PA promotes fibrin clearing Anti-coagulant - Heparin like molecules on endothelium inactivate thrombin and several coagulation factors |
|
What are the 4 major classes of drug that prevent or diminish thrombus formation?
|
Anticoagulants - prevent clot
Direct Thrombin Inhibitors - lyse thrombi via catalyzing formation of plasmin Fibrinolytic - dissolve existing thrombi Anti-platelet - interfere with platelet activity |
|
What is the specific effect of anti-platelet agents?
|
They inhibit platelet activation and adhesion and therefore prevent activation of clotting factors and fibrin formation
|
|
What is the specific effect of anti-coagulants?
|
They inhibit the coagulation cascade and therefore fibrin formation.
|
|
How do Fibrinolytic agents work?
|
They activate plasminogen to plasmin
|
|
What are the 3 classes of anticoagulant?
|
Heparins
Vitamin K antagonists Direct thrombin inhibitors |
|
What is the unique sequence responsible for Heparin's activity?
|
pentasaccharide
|
|
How do all Heparin's work?
|
By enhancing the activity of the antithrombin and increasing its affinity for thrombin
The thrombin-antithrombin complex also inhibits factors 10a, 9a, and 11a. |
|
What are some important characteristics of Unfractionated Heparin?
|
Half life = 60-90 minutes
Does not cross BBB Not absorbed orally Does not cross placenta Dose dependent kinetics |
|
What are the adverse effects?
|
Bleeding
Thrombocytopenia Long term = osteoporosis, alopecia |
|
How does LMWH work?
|
It selectively inhibits factor 10a
|
|
What are some important characteristics of LMWH?
|
Better sc bioavailability
Longer acting Lab monitoring not required Lower risk of thrombocytopenia and osteoporosis. |
|
Name 3 Vitamin K antagonists
|
Warfarin
Dicoumoral Phenindione |
|
How does Warfarin work?
|
It inhibits the synthesis of vitamin k dependent clotting factors and protein C
Synthesis requires gamma-carboxylation which oxidizes vitamin K (therefore it must be reduced) Warfarin inhibits vitamin K epoxide reductase and therefore reduction of Vitamin K. |
|
Does warfarin have a fast or slow onset of action?
|
slow - 3 to 5 days
|
|
What is important to realize when considering co-administration with Warfarin?
|
That 97-99.9% is bound to plasma proteins and therefore inactive. Co-administration may displace some of the warfarin and lead to greater amounts in the blood.
|
|
What is Pro-thrombin Time?
|
The time plasma takes to clot after tissue factor is added. Measures the quality of the extrinsic pathway.
|
|
What is the problem with PTT?
|
Different labs may have different results based on batches of TF used.
INR is used to standardize the results. |
|
Describe the different tests reviewed based on anticoagulant given.
|
Heparin = PTT
Warfarin = PT/INR LMWH = Anti- 10a |
|
Describe the conversion of Heparin to Warfarin.
|
Use concomitantly for a minimum of 4 days which is the time to peak therapeutic effect of warfarin
|
|
What is the reversal agent for Heparin?
|
Protamine sulfate
|
|
What is the reversal agent for LMWH (Lovenox)?
|
Protamine sulfate
|
|
What is the reversal agent for Warfarin?
|
Vitamin K
|
|
What is the MOA for Direct Thrombin Inhibitors?
|
Direct binding of Thrombin active site.
Inhibit Fibrinogen to Fibrin Not mediated via anti-thrombin or vitamin K |
|
What is the MOA for Fibrinolytic drugs?
|
They are plasminogen activators which convert plasminogen into plasmin that catalyzes the degradation of fibrin
|
|
What are they used for?
|
Lysis of already formed clots
PE MI |
|
Name 4 Fibrinolytic agents?
|
Streptokinase (1) -bacterial protein
Urokinase (1) - Human enzyme Alteplase (2) - Human t-PA Reteplase/Tenecteplase (3) - Mutant variants of t-PA with increased plasma half lifes |
|
What is unique about Alteplase?
|
It preferentially binds activates plasminogen bound to fibrin confining fibrinolysis to formed thrombi.
It avoids systemic activation |